Your browser doesn't support javascript.
loading
Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.
Coriat, P; Guidet, B; de Hert, S; Kochs, E; Kozek, S; Van Aken, H.
Affiliation
  • Coriat P; Paris, France.
  • Guidet B; Saint Antoine, France.
  • de Hert S; Ghent, Belgium.
  • Kochs E; Munich, Germany.
  • Kozek S; Vienna, Austria.
  • Van Aken H; Muenster, Germany hva@uni-muenster.de.
Br J Anaesth ; 113(1): 194-5, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24942721
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Resuscitation / Hydroxyethyl Starch Derivatives / Plasma Substitutes / Fluid Therapy Limits: Humans Language: En Journal: Br J Anaesth Year: 2014 Document type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Resuscitation / Hydroxyethyl Starch Derivatives / Plasma Substitutes / Fluid Therapy Limits: Humans Language: En Journal: Br J Anaesth Year: 2014 Document type: Article Affiliation country: France